Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

SPTAN1 variants likely cause autosomal recessive complicated hereditary spastic paraplegia

Abstract

Heterozygous mutations in SPTAN1 are associated with a broad phenotypical spectrum ranging from axonal neuropathy phenotypes to neurodevelopmental phenotypes with or without epilepsy. Recently, biallelic mutations in SPTAN1 were reported as a potential cause of autosomal recessive pure hereditary spastic paraplegia (HSP). However, no further HSP cases with biallelic SPTAN1 mutations have been reported. Herein, we report the clinical and genetic findings of a patient with complicated HSP likely caused by a novel homozygous SPTAN1 mutation. A patient with complicated HSP from a consanguineous family was recruited. The proband underwent detailed neurological examinations. Homozygosity mapping was performed in the proband and her healthy sister. Whole exome sequencing was performed in the proband. Our patient had early onset motor symptoms with upper motor neuron paralysis and intellectual disability, which is compatible with complicated HSP. Genetic analysis identified a rare homozygous missense mutation in SPTAN1 (c.4162A>G, p.I1388V), which was predicted to be deleterious by in silico tools. Her healthy parents and sister all carried the heterozygous mutation. Our results provided further support for the association of biallelic SPTAN1 variants with HSP and suggested that screening for the SPTAN1 gene should be considered not only in patients with pure HSP but also in patients with complicated HSP.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

References

  1. Syrbe S, Harms FL, Parrini E, Montomoli M, Mutze U, Helbig KL, et al. Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy. Brain. 2017;140:2322–36.

    Article  Google Scholar 

  2. Gartner V, Markello TC, Macnamara E, De Biase A, Thurm A, Joseph L, et al. Novel variants in SPTAN1 without epilepsy: an expansion of the phenotype. Am J Med Genet A. 2018;176:2768–76.

    CAS  PubMed  Google Scholar 

  3. Beijer D, Deconinck T, De Bleecker JL, Dotti MT, Malandrini A, Urtizberea JA, et al. Nonsense mutations in alpha-II spectrin in three families with juvenile onset hereditary motor neuropathy. Brain. 2019;142:2605–16.

    Article  Google Scholar 

  4. Dong HL, Chen L, Wu ZY. A novel de novo SPTAN1 nonsense variant causes hereditary motor neuropathy in a Chinese family. Brain. 2021;144:e11.

    Article  Google Scholar 

  5. Ylikallio E, Ritari N, Sainio M, Toppila J, Kivirikko S, Tyynismaa H, et al. De novo SPTAN1 mutation in axonal sensorimotor neuropathy and developmental disorder. Brain. 2020;143:e104.

    Article  Google Scholar 

  6. Leveille E, Estiar MA, Krohn L, Spiegelman D, Dionne-Laporte A, Dupre N, et al. SPTAN1 variants as a potential cause for autosomal recessive hereditary spastic paraplegia. J Hum Genet. 2019;64:1145–51.

    Article  CAS  Google Scholar 

  7. Bennett V, Healy J. Organizing the diseases fluid membrane bilayer: diseases linked to spectrin and ankyrin. Trends Mol Med. 2008;14:28–36.

    Article  CAS  Google Scholar 

  8. Huang CY, Zhang C, Zollinger DR, Leterrier C, Rasband MN. An alphaII spectrin-based cytoskeleton protects large-diameter myelinated axons from degeneration. J Neurosci. 2017;37:11323–34.

    Article  CAS  Google Scholar 

  9. Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511:344–7.

    Article  CAS  Google Scholar 

  10. Hamdan FF, Saitsu H, Nishiyama K, Gauthier J, Dobrzeniecka S, Spiegelman D, et al. Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy. Eur J Hum Genet. 2012;20:796–800.

    Article  CAS  Google Scholar 

  11. Yavarna T, Al-Dewik N, Al-Mureikhi M, Ali R, Al-Mesaifri F, Mahmoud L, et al. High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders. Hum Genet. 2015;134:967–80.

    Article  CAS  Google Scholar 

  12. Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18:696–704.

    Article  CAS  Google Scholar 

  13. Saitsu H, Tohyama J, Kumada T, Egawa K, Hamada K, Okada I, et al. Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay. Am J Hum Genet. 2010;86:881–91.

    Article  CAS  Google Scholar 

  14. Writzl K, Primec ZR, Strazisar BG, Osredkar D, Pecaric-Meglic N, Kranjc BS, et al. Early onset West syndrome with severe hypomyelination and coloboma-like optic discs in a girl with SPTAN1 mutation. Epilepsia. 2012;53:e106–10.

    Article  CAS  Google Scholar 

  15. Nonoda Y, Saito Y, Nagai S, Sasaki M, Iwasaki T, Matsumoto N, et al. Progressive diffuse brain atrophy in West syndrome with marked hypomyelination due to SPTAN1 gene mutation. Brain Dev. 2013;35:280–3.

    Article  Google Scholar 

  16. Tohyama J, Nakashima M, Nabatame S, Gaik-Siew C, Miyata R, Rener-Primec Z, et al. SPTAN1 encephalopathy: distinct phenotypes and genotypes. J Hum Genet. 2015;60:167–73.

    Article  CAS  Google Scholar 

  17. Ream MA, Mikati MA. Clinical utility of genetic testing in pediatric drug-resistant epilepsy: a pilot study. Epilepsy Behav. 2014;37:241–8.

    Article  Google Scholar 

  18. Rapaccini V, Esposito S, Strinati F, Allegretti M, Manfroi E, Miconi F, et al. A Child with a c.6923_6928dup (p.Arg2308_Met2309dup) SPTAN1 Mutation Associated with a Severe Early Infantile Epileptic Encephalopathy. Int J Mol Sci. 2018;19:1976–81.

    Article  Google Scholar 

  19. Stavropoulos DJ, Merico D, Jobling R, Bowdin S, Monfared N, Thiruvahindrapuram B, et al. Whole genome sequencing expands diagnostic utility and improves clinical management in pediatric medicine. NPJ Genom Med. 2016;1:15012–20.

    Article  CAS  Google Scholar 

  20. Terrone G, Pinelli M, Bernardo P, Parrini E, Imperati F, Brunetti-Pierri N, et al. Intrafamilial variability in SPTAN1-related disorder: From benign convulsions with mild gastroenteritis to developmental encephalopathy. Eur J Paediatr Neurol. 2020;28:237–9.

    Article  Google Scholar 

Download references

Acknowledgements

We thank the patient and her family members for their participation.

Funding

This study was supported by the Science Technology Department of Zhejiang Province (2019C03017), the Zhejiang Province Medical and Health Technology Program (Pro. nos. 2018261205 and 2018250963).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wei Luo.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xie, F., Chen, S., Liu, P. et al. SPTAN1 variants likely cause autosomal recessive complicated hereditary spastic paraplegia. J Hum Genet 67, 165–168 (2022). https://doi.org/10.1038/s10038-021-00975-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-021-00975-1

This article is cited by

Search

Quick links